Significados de bivalent vaccine en inglés

Here we applied this approach to develop a bivalent vaccine against pneumococcus and S. typhi.

Cross-reactive seropositivity is more common in women with high anti-HPV16 antibody response and in the bivalent vaccine recipients.

We developed in this study a bivalent vaccine against the two viruses through a recently developed polyvalent complex platform.

Vaccination with the bivalent vaccine at day 1 resulted in a decreased spleen colonization by both Salmonella Infantis and Enteritidis.

We conducted a cost-utility analysis of screening and immunization with the bivalent vaccine for the Canadian setting from the Ministry of Health perspective.

In particular, the bivalent vaccine provides additional protection against HPV 31, 33, and 45 and the quadrivalent vaccine against HPV31.

Here, we expand our investigation of the immunogenic properties of these bivalent vaccines in mice.